UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021024
Receipt number R000024161
Scientific Title Will simple home Waon (thermal) therapy improve circulatory status and oxidative stress long term after Fontan operation? -First Waon (thermal) therapy trial in patients after Fontan operation
Date of disclosure of the study information 2016/02/15
Last modified on 2023/08/22 16:19:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Will simple home Waon (thermal) therapy improve circulatory status and oxidative stress long term after Fontan operation?
-First Waon (thermal) therapy trial in patients after Fontan operation

Acronym

Simple home Waon (thermal) therapy for the patients long term after Fontan operation

Scientific Title

Will simple home Waon (thermal) therapy improve circulatory status and oxidative stress long term after Fontan operation?
-First Waon (thermal) therapy trial in patients after Fontan operation

Scientific Title:Acronym

Simple home Waon (thermal) therapy for the patients long term after Fontan operation

Region

Japan


Condition

Condition

Patients long term after Fontan operation

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the hypothesis that home Waon therapy may acutely and chronically improve the hemodynamics, oxidative stress, exercise tolerance in the patients long term after Fontan patients

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Noninvasively obtained hemodynamic and cardiovascular function, heart rate variability, exercise tolerance, daily work, oxidative stress, neurohormone at 6 months after Waon therapy

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Waon therapy using far infrared dome sauna five times a week over one year

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

More than 1 year after Fontan operation
Age > 6 years
Patients who wish to participate the Waon therapy

Key exclusion criteria

severe heart failre
no consent to participate the study
patients who are not suitable for Waon theraphy, judged by attending physician

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Satoshi
Middle name
Last name Masutani

Organization

Saitama Medical Center Saitama Medical University

Division name

Pediatric Cardiology

Zip code

350-8550

Address

1981 Kamoda, Kawagoe-shi, SAITAMA 350-8550, JAPAN

TEL

049-228-3550

Email

smstn@ka2.so-net.ne.jp


Public contact

Name of contact person

1st name Satoshi
Middle name
Last name Masutani

Organization

Saitama Medical Center Saitama Medical University

Division name

Pediatric Cardiology

Zip code

350-8550

Address

1981 Kamoda, Kawagoe-shi, SAITAMA 350-8550, JAPAN

TEL

049-228-3400

Homepage URL


Email

smstn@ka2.so-net.ne.jp


Sponsor or person

Institute

Saitama Medical Center Saitama Medical University

Institute

Department

Personal name



Funding Source

Organization

Miyata cardiac research promotion foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB, Saitama Medical Ctr

Address

1981, Kamoda, Kawagoe, Saitama, zip 350-8550, Japan

Tel

049-228-3902

Email

smcrinri@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 02 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 09 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 02 Month 15 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 02 Month 15 Day

Last modified on

2023 Year 08 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024161


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name